Methylmercury is known to cause fetal cleft palate in mice (Spyker and Smithberg, 1972; Inouye and Murakami, 1975; Su and Okita, 1976; Olson and Massaro, 1977a, b; Fuyuta et al., 1978; Fuyuta et al., 1979; . Inouye and Murakami (1975) reported that an oral dose of 30 mg/kg of MMC caused cleft palate in 100% of surviving fetuses (50% of implants) in DDN mice. This provided evidence for the teratogenicity of MMC. Other investigators also demonstrated that methylmercury given to pregnant mice induced cleft palate at a significant frequency in fetuses of 129/SVS1 and A/J mice (Spyker and Smithberg, 1972) and gpc mice (Kawabe et al., 1973), although considerable numbers of the fetuses died or were absorbed in these systems. On the other hand, Fuyuta et al. (1979) reported that a single oral administration of 25 mg/kg of MMC to ICR mice on day 10 of pregnancy induced cleft plate in 100% of the fetuses, while the proportion of dead and absorbed fetuses was as low as 11.9%©. ICR mice thus appear to be a useful strain for investigating the induction of cleft palate by MMC.
The present study was undertaken as a first step to clarify the mechanisms of cleft palate induction by MMC in ICR mice. That is, the process of palate formation in the untreated ICR fetus was established, and this was then compared with the situation in the treated fetus.
Materials and Methods
ICR mice were used as experimental animals. Mature nulliparous females (12-18 weeks, 25-35 g) in proestrus were caged overnight with mature males, and were examined for copulation on the following morning. The day of observation of vaginal plug was defined as day 0 of gestation. In the calculation of the chronological age of the fetuses, fertilization was assumed to have taken place at 2:00 a .m. (Snell et al., 1940) . The fetuses obtained at each time period of gestation mentioned below were fixed in Bouin's solution and examined under a dissecting microscope for malformation. A. The pregnant mice were divided into three groups as follows: 1) Untreated group: Twenty-two pregnant mice were used. Fetuses were obtained between 14 days 10 hours of pregnancy (abbreviated as 14/10) and 14/22 at intervals of 2 hours for examination. 3) MMC-treated group, "Treated (1)": Thirty-eight females were used and were given 25 mg/kg of MMC orally ast 10/08 of pregnancy. The dams were then sacrificed between 14/10 and 15/00, and between 15/06 and 16/00 at intervals of 2 hours. In order to investigate the mode of palate closure, a morphological rating (=MR; Walker and Crain, 1960 ) and a stage of palate development (Walker and Fraser, 1956 ) were assigned to each fetus. The time course of palate development and the relation of palate stage to MR were examined, and the results were compared with those in the untreated group. 3) Positive control group, "Treated (2)": Ten pregnant mice were given 25 mg/kg of MMC orally at 10/08 of pregnancy. Their fetuses were examined on day 18 of pregnancy for cleft palate and other teratological features.
B. In order to assess the ciritical period for induction of cleft palate by MMC treatment using the present system, 25 mg/kg of MMC was given orally to 5 females each at 9/08, 10/08, 11/08, 12/08 and 13/08. Their fetuses were then examined for cleft palate on day 18 of pregnancy.
Results Table 1 summarizes the external abnormalities which appeared in fetuses of the treated group. Generalized edema was noted in as many as 90% of the fetuses between 14/10 and 15/00 of pregnancy. Such edema, however, subsided as the period of gestation advanced and disappeared on day 18 of pregnancy. In this group, cleft palate occurred in 99% of the fetuses judged from the results of examination in the positive control group on day 18 of pregnancy.
The process of palate formation in fetuses of the untreated group was examined in terms of the distribution of fetuses in palate developmental stages at each MR, and the results were compared with those for A/Jax and C57/BL mice described by Trasler (1965) as shown in Table 2 . In ICR and A/Jax mice, palate closure tended to occur later than in C57/BL mice. The palate shelf horizontalization represented as palate stage 3 and 4 (Walker and Fraser, 1956) in ICR mice occurred between MR 9 and 11, which was approximately similar to A/Jax mice. Fetuses with incomplete fusion of the palate shelves (palate stage 6) were observed up to MR 15 in ICR mice, but until MR 12 in A/Jax mice where complete fusion (palate stage 7) occurred between MR 10 and 14 in most fetuses. This implies that the palate formation of ICR mice may progress more slowly than that of A/Jax. Table 3 shows the distribution of fetuses The time when more than 50% of fetuses reached over stage 2 was earlier than 14/10 in the untreated group, whereas it was between 14/14 and 14/16 in the treated group. This suggests that the progress of palate development prior to horizontalization is delayed in the MMC treated fetuses (Table 3) . Table 4 shows the relationship between fetal palate stage and its MR in the untreated and treated groups. In both groups, palate stages 1 and 2 began to appear at almost the same MR. At MR 12, when horizontalization was completed (palate stage 5) in the untreated group, the palate shelves of more than half of the fetuses in the treated group were at palate stage 2. Moreover, at MR 17, the palate shelves of all the fetuses in the untreated group were fused, but the palate shelves were still in a vertical plane (palate stage 2) in many fetuses of the treated group, although some fetuses were at stages 3 or 4. There was one exceptional fetus which reached palate stage 7 at MR 22 in the treated group.
The horizontalization of the palate shelf thus occurred up to 14/18 of pregnancy in the fetuses of the untreated group followed by completion of fusion of the shelves. On the other hand, in the fetuses of the treated group, the horizontalization of the palate shelf was retarded and then their fusion failed to occur. Table 5 summarizes the incidence of cleft palate induced by MMC given to pregnant ICR mice in a dose of 25 mg/kg on different days of gestation. Cleft palate was observed in 100% of the fetuses from dams treated with MMC on day 10, 11 or 12 of pregnancy, whereas cleft palate occurred at a significantly lower rate (40 or 35.7%) in fetuses from dams treated on day 9 or 13. These findings indicate that the critical period of MMC administration for cleft palate induction at a high frequency is the days between 10 and 12 of pregnancy.
Discussion
Palate closure in the normal 1CR fetus takes place on day 14 of gestation and is almost completed by 14/18, which is about one day earlier than in the Ai.lax fetus (Walker and Fraser, 1956 ), while the developmental stage (MR) of the fetus at which palate closure occurs is the same in the two strains. On the other hand. Greene and Kochhar (1973) have shown that palate closure in ICR/DUB mice occurred between 14/00 and 14/08. This discrepancy in time of completion of palate closure between our data and thirs may be attributable to the difference in mating intervals, that is, females mated with males for 16 hours in our study but for only 4 hours in the study of Greene and Kochhar (1973) . The critical period of MMC treatment (See Materals and Methods) for 100% fetal cleft palate induction was between 10 days and 12 days of pregnancy. Moreover, the same treatment on day 13 of grstation caused a relatively low incidence of cleft palate (Table 5 ). These findings can be interpreted on the basis of the threshold concept (Fraser, 1976) . That is, in more than half of the fetuses in the latter group, palate formation had already proceeded beyond the stage sensitive to MMC, at which MMC exerted an inhibitory effect on the development of the fetuses.
On the other hand, it seems curious that only 40% of fetuses had celft palate in the day 9 treated group (Table 5) , since methylmercury has been shown to penetrate through the placenta to the fetus and to stay in the fetal tissues for a long term, when methylmercury was given to the pregnant mouse (Berlin and Ullberg, 1963; Olson and Massaro, 1977a) . The action of methylmercury taken into the fetus, however, must be altered with the time of administration as shown by Olson and Massaro (1977a) , although the mode of MMC administration was different in the present study from that in Olson and Massaro (1977a) . Then, it seems reasonable to consider that the rate of the increase of Hg pool size in the fetus in the present system was also different in accord with the day of treatment. On the other hand, generalized edema of the fetus appeared in the period of normal palate formation and thereafter subsided in the present study (Table 1 ). This suggests that the effect of methylmercury on the physiological condition of the fetus became reduced from 5 days after administration on day 10 of gestation. This is in harmony with the mode of alteration of the Hg concentration described by Olson and Massaro (1977a) . In conclusion, in the day 9 treated group shown in Table 5 , it is suspected that the toxic insult of the methylmercury was also reduced by a decrease in the Hg concentration in the fetuses of day 9 treated group. In addition, the reduction of the insult must occur in more than half of the fetus before the time when the development of the palate shelf reached the threshold stage, that is the rotation stage susceptible to MMC (Fraser, 1976) .
The data obtained in the present study (Tables 3 and 4 ) clearly indicate that MMC seriously retards the horizontalization of the palate shelf in the ICR fetus. As shown in Table 3 , more than half of the fetuses remained at palate stage 2 up to the end of the period examined (16/00), and few fetuses had contact palate shelves (stage 5). On the other hand , development or growth of the MMC treated fetuses as represented by MR in the present study , proceeded throughout the period of observation. It can be said that the width of the manidble is too large to permit contact of the bilateral palate shelves with each other in MMC treated fetuses , when delayed rotation of the shelves may occur .
Palate closure was also delayed in ICR/ DUB mice when they were treated with cortisone, as reported by Greene and Kochhar (1973) , although it was simultaneously shown that the bilateral palate shelves of all fetuses from the cortisone treated mice moved to the horizontal position corresponding to palate stage 4 by day 15. There may thus be some difference in the effects on palate closure of MMC and cortisone.
The present results indicated that the time when the fetuses reach palate stage 2, which is the phase immediately before palate shelf horizontalization, may be retarded in the MMC treated group as compared to the untreated group (Table  3) . If it is true, MMC must delay the development of the palate shelf itself. Quantitative analysis is needed to evaluate this possibility, including an assessment of whether the delay in the time at which the MMC treated fetuses reach palate stage 2 is significant or not.
For this purpose, however, some alteration of the method for determining the stage of palate development would be required as described by Biddle (1980) . He employed 9 arbitrary stages of palate development modified from Walker and Fraser (1956) and Trasler (1965) to designate the developing A/Jax or A.B6F1 fetuses. Moreover, there is also the question that the distribution of fetuses in relation to palate development stages in the MMC treated group is not same with that in the untreated group, since palate closure is never actually completed in the MMC treated fetuses, although the closure is completed by 15/06 in the untreated group. It may then be difficult to compare the development of palate shelf in the MMC treated fetus with that in the untreated fetus using the ordinary quantitative methods such as probit analysis without postulating some compromising construction of a prerequisite for the distribution of subject to the quantitative comparison.
Be that as it may, the present results clearly document the mode of cleft palate induction by MMC most precisely. relations in the oral cavity of cortisonetreated mouse fetuses during the time of secondary palate closure. Teratology,
